At Gordon & Franklin, we focus on strengthening clinical safety and readiness in clinical research, particularly within early-phase and high-risk studies. Drawing on extensive experience across acute clinical practice, medical education and research delivery, we bring a practical, safety-led approach to supporting sponsors, CROs and research sites. 

We have over 13 years’ experience working closely alongside the MHRA within early-phase clinical research environments, including supporting sites through successful Phase I accreditation and inspection processes.

Our work centres on preparing teams for the realities of trial delivery. Through protocol-specific education, clinical safety readiness assessments, and scenario-based training, we help bridge the gap between protocol understanding and real-world clinical response. This includes supporting teams to recognise adverse events early, escalate appropriately and work confidently under pressure. 

Rather than offering generic training, our approach is tailored to each specific study and its associated risks, ensuring that preparation is both relevant and actionable. The aim is simple: to support safer trial delivery, stronger team confidence and more consistent patient care.

For organisations looking to enhance clinical safety, improve preparedness and strengthen trial delivery, Gordon & Franklin offers a focused and practical partnership grounded in real clinical experience.